Novartis, the Swiss multinational pharma giant, carried out the most clinical trials in Japan since 2012, with almost 150.
It’s followed by GlaxoSmithKline, with just over 100.
The remaining top ten are Takeda, Bayer, Astellas, AstraZeneca, Eli Lilly, Daiichi Sankyo, Merck, and Pfizer.
